Development of new glucosylated derivatives of gadolinium diethylenetriaminepentaacetic for magnetic resonance angiography
- PMID: 12908699
Development of new glucosylated derivatives of gadolinium diethylenetriaminepentaacetic for magnetic resonance angiography
Abstract
Rationale and objectives: A possible approach for the extension of the vascular residence time of contrast agents relies on the renal reabsorption mechanisms of some molecules such as glucose. In this study, various small-molecular-weight glucosyl derivatives of gadolinium diethylenetriaminepentaacetic (Gd-DTPA) were synthesized and their vascular half-life was studied.
Methods: Several Gd-DTPA-bisamides carrying glucosyl groups bound by different linkers were prepared. The pharmacokinetics and biodistribution of these compounds were determined on Wistar rats.
Results: The sugar moieties linked to Gd-DTPA efficiently reduce the renal excretion of some derivatives. The interaction with renal carrier has not been clearly demonstrated, nor was any interaction observed with blood components.
Conclusions: Two of the new glucosylated derivatives of Gd-DTPA (Cd-DTPA-BC2-beta-cellobionA 2 and Gd-DTPA-BC4-beta-glucosylA 7) can be proposed as blood-pool MR contrast agents, considering their vascular remanence.
Similar articles
-
Cascade polymeric MRI contrast media derived from poly(ethylene glycol) cores: initial syntheses and characterizations.Biomacromolecules. 2007 May;8(5):1519-29. doi: 10.1021/bm061141h. Epub 2007 Apr 3. Biomacromolecules. 2007. PMID: 17402781
-
In vivo MR detection of vascular endothelial injury using a new class of MRI contrast agent.Bioorg Med Chem Lett. 2004 Jun 7;14(11):2787-90. doi: 10.1016/j.bmcl.2004.03.066. Bioorg Med Chem Lett. 2004. PMID: 15125933
-
A comparative evaluation of CH3-DTPA-Gd (NMS60) for contrast-enhanced magnetic resonance angiography.Magn Reson Imaging. 2004 Jun;22(5):619-24. doi: 10.1016/j.mri.2004.01.044. Magn Reson Imaging. 2004. PMID: 15172054
-
Magnetic resonance coronary angiography: comparison between a Gd-BOPTA- and a Gd-DTPA-enhanced spoiled gradient-echo sequence and a non-contrast-enhanced steady-state free-precession sequence.Acta Radiol. 2009 May;50(4):406-11. doi: 10.1080/02841850902838066. Acta Radiol. 2009. PMID: 19308763
-
Intercellular imaging by a polyarginine derived cell penetrating peptide labeled magnetic resonance contrast agent, diethylenetriamine pentaacetic acid gadolinium.Chin Med J (Engl). 2007 Jan 5;120(1):50-5. Chin Med J (Engl). 2007. PMID: 17254488
Cited by
-
Synthesis and Biological Evaluation of a Novel Glucosylated Derivative of Gadolinium Diethylenetriaminepentaacetic Acid for Tumor Magnetic Resonance Imaging.Iran J Pharm Res. 2019 Winter;18(1):49-60. Iran J Pharm Res. 2019. PMID: 31089343 Free PMC article.
-
Imaging of Human Insulin Secreting Cells with Gd-DOTA-P88, a Paramagnetic Contrast Agent Targeting the Beta Cell Biomarker FXYD2γa.Molecules. 2018 Aug 21;23(9):2100. doi: 10.3390/molecules23092100. Molecules. 2018. PMID: 30134599 Free PMC article.
-
MR angiography with blood pool contrast agents.Eur Radiol. 2007 Dec;17(12):3017-24. doi: 10.1007/s00330-007-0712-0. Epub 2007 Jul 17. Eur Radiol. 2007. PMID: 17639407 Review.
-
Cellular uptake and imaging studies of glycosylated silica nanoprobe (GSN) in human colon adenocarcinoma (HT 29 cell line).Int J Nanomedicine. 2013;8:3209-16. doi: 10.2147/IJN.S44815. Epub 2013 Aug 21. Int J Nanomedicine. 2013. PMID: 23986637 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources